• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Inbrija

Joe Frazier standing over Muhammad Ali after knocking him down in the Fight of the Century in 1971
Marketing

Merz steps into the ring with Muhammad Ali-inspired Inbrija push

Merz has launched a punchy Parkinson’s campaign, working Muhammad Ali quotes and footage into a revised version of the “For the Fighters” initiative.
Nick Paul Taylor Feb 5, 2026 9:50am
Merz Therapeutics Merz CEO Stefan Knig

Merz to expand and hunt for more deals after closing Inbrija buy

Jul 11, 2024 4:08pm
Acorda Therapeutics Inbrija ad

Acorda fights on with new Inbrija ad ahead of bankruptcy sale

Jun 3, 2024 11:52am
for sale sign

Acorda files for bankruptcy, inks $185M asset deal to Merz

Apr 9, 2024 8:29am
Acorda Therapeutics

Biogen returns ex-U.S. rights of MS drug Fampyra to Acorda

Jan 11, 2024 1:15pm
Acordas new Inbrija website

Fighting talk: Acorda gets combative in new Parkinson's campaign

Aug 3, 2023 8:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings